iNATT logo
www.inatt.org
enquiries@inatt.org

Clinical Trial Now Open in UK

An open label, single arm, multi-centre, phase 2 trial of lenvatinib for the treatment of anaplastic thyroid cancer (ATC)

 

3 UK centres are being opened:

The Royal Marsden Hospital: London (Dr Kate Newbold)

Velindre Cancer Centre: Cardiff (Dr Laura Moss)

Beatson West of Scotland Cancer Centre: Glasgow (Prof Nick Reed)

 

Dr. Laura Moss
Velindre Hospital, Velindre Road, Whitchurch, Cardiff, CF14 2TL
enquiries@inatt.org